Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy is a research paper published in Multiple Sclerosis and Related Disorders (2022). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R33 CA263705
NCI NIH HHS
Grant: U24 CA224319
NCI NIH HHS
Grant: P30 CA196521
NIDDK NIH HHS
Grant: U01 DK124165
National Institutes of Health
Grant: 1P30CA196521-01
Mouse Genetics
National Institutes of Health
Grant: 1R33CA263705-01
PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials
National Institutes of Health
Grant: 5U24CA224319-04
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials
National Institutes of Health
Grant: 5U01DK124165-02
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals